Dr. Yoko Momoyama, MD

Dr. Momoyama practices at Duly Health and Care - Lombard in Lombard, Illinois.

Dr. Momoyama's NPI, 1801863253, was assigned on March 3, 2006. Dr. Momoyama graduated from New York Medical College in 1996. Dr. Momoyama holds Illinois license 036104066.

Dr. Momoyama's primary practice is Duly Health and Care - Lombard, at 1801 S Highland Ave, Lombard, IL 60148. The practice phone is (630) 967-2000.

Dr. Momoyama's primary practice is Duly Health and Care - Lombard in Lombard, Illinois. Dr. Momoyama is also affiliated with Elmhurst Hospital. The medical group on file is DuPage Medical Group. Dmand AI also links Dr. Momoyama to 1 more hospital, 2 home health agencies, 2 hospices, 1 group practice or clinic and 1 skilled nursing facility, each named with a free account. Dr. Momoyama's employer is on file too: a physical therapy & rehab clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Momoyama practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Momoyama's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Momoyama is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Momoyama's licenses on file in 2 states: Illinois and Arizona.

Dmand AI lists acid reflux, acute mini-stroke (TIA), acute sinusitis, acute skin infection, adjustment disease, alzheimer's disease, aneurysm and anxiety among the conditions Dr. Momoyama treats.

CMS data shows 5,005 Medicare services from Dr. Momoyama across 46 procedure codes in 2024, for 392 Medicare patients. Medicare paid $191,131 for them. Every service was in an office.

CMS counts 392 Medicare patients who saw Dr. Momoyama in 2024. The largest group is 65 to 74, with 175 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Momoyama's median patient age at 70, with 70% women.

In 2024, Dr. Momoyama wrote 13,779 Medicare Part D claims for 679 patients. 90% of them were for generic drugs. CMS names the drug for 12,964 of them, across 186 drugs with 11 or more claims each, at $913,846 in total drug cost. In 2023, CMS named 12,910 claims across 178 drugs.

Dr. Momoyama accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Momoyama as offering telehealth.

Dmand AI links Dr. Momoyama to 3 clinical trials. 3 are still active or recruiting. Conditions studied include Alzheimer Disease, Death and Diabetes Mellitus, Type 2. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Momoyama that name 2 trials.

CMS Open Payments shows 90 general payments to Dr. Momoyama from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. Merck Sharp & Dohme Corporation paid the most, $872. It also lists 3 research payments totaling $9,007 from 2022 to 2024, naming 2 clinical trials.

Dmand AI lists 3 awards for Dr. Momoyama, most recently CMS Stage 1 EHR in 2014.

Dr. Momoyama graduated from New York Medical College in 1996. Dr. Momoyama is a member of ACP.

Dr. Momoyama is in network with 14 carriers, including Aetna, HCSC and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.